Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization-Associated with Best Vitelliform Macular Dystrophy

被引：0
|
作者：
Grigorian, Florin [1 ]
Vasconcelos, Huber Martins [1 ]
Bailey, Steven T. [1 ]
Lujan, Brandon J. [1 ]
Campbell, J. Peter [1 ]
Lin, Phoebe [1 ]
Weleber, Richard G. [1 ]
Pennesi, Mark E. [1 ]
Yang, Paul [1 ]
机构：
[1] OHSU Casey Eye Inst, Portland, OR USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3145
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy
    Querques, Giuseppe
    Bocco, Maria C. Angulo
    Soubrane, Gisele
    Souied, Eric H.
    ACTA OPHTHALMOLOGICA, 2008, 86 (06) : 694 - 695
  • [2] Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
    Mandal, Subrata
    Sinha, Subijay
    Venkatesh, Pradeep
    Vashisht, Nagender
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2011, 59 (03) : 262 - U97
  • [3] INTRAVITREAL ANTI-VEGF THERAPY IN A CASE OF CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH PSEUDOXANTHOMA ELASTICUM
    Fruschelli, M.
    Capozzoli, M.
    Fazio, S.
    Haka, G.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E83 - E83
  • [4] Persistent macular oedema following Best vitelliform macular dystrophy undergoing anti-VEGF treatment
    Lin, Tie-Zhu
    Pazo, Emmanuel Eric
    Ren, Yue
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (05) : 838 - 840
  • [5] Persistent macular oedema following Best vitelliform macular dystrophy undergoing anti-VEGF treatment
    Tie-Zhu Lin
    Emmanuel Eric Pazo
    Yue Ren
    Li-Jun Shen
    International Journal of Ophthalmology, 2022, 15 (05) : 838 - 840
  • [6] Choroidal neovascularization complicating Best's vitelliform macular dystrophy in a child
    Elkhoyaali, A.
    Chatoui, S.
    Bercheq, N.
    Elouatassi, N.
    Zerrouk, R.
    Elasri, F.
    Reda, K.
    Oubaaz, A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (01): : 69 - 73
  • [7] Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child
    Chhablani, Jay
    Jalali, Subhadra
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (04) : 677 - 679
  • [8] Choroidal Neovascularization Is Common in Best Vitelliform Macular Dystrophy and Plays a Role in Vitelliform Lesion Evolution
    Han, Ian C.
    Coussa, Razek Georges
    Mansoor, Mahsaw
    Critser, D. Brice
    Sohn, Elliott H.
    Russell, Jonathan F.
    Stone, Edwin M.
    OPHTHALMOLOGY RETINA, 2023, 7 (05): : 441 - 449
  • [9] Functional and Anatomic Changes in Bilateral Choroidal Neovascularization Associated with Vitelliform Macular Dystrophy After Intravitreal Bevacizumab
    Cennamo, Gilda
    Cesarano, Ida
    Vecchio, Elisabetta Chiariello
    Reibaldi, Michele
    de Crecchio, Giuseppe
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 643 - 646
  • [10] Intravitreal bevacizumab treatment for exudative choroidal neovascularisation in best vitelliform macular dystrophy
    Jarc-Vidmar, Martina
    Sega, Rok
    Jaki-Mekjavic, Polona
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (02) : NP44 - NP49
12345